A Case Based Approach For the Treatment of Hyperkalemia in Patients with Heart Failure
Dr. Heywood
Relypsa, a Vifor Pharma Group company, aims to focus in iron deficiency, nephrology and cardio-renal therapeutic areas. We strive to help improve the lives of patients with severe and chronic diseases. The materials and content in this virtual exhibit are intended for US Healthcare professionals only. If you are not a US Healthcare professional, please visit www.viforpharma.com
Resources:
Published
November 11, 2020
Created by
